Metabolic vulnerability of cisplatin-resistant cancers

Obrist, F; Michels, J; Durand, S; Chery, A; Pol, J; Levesque, S; Joseph, A; Astesana, V; Pietrocola, F; Wu, GS; Castedo, M; Kroemer, G

Castedo, M; Kroemer, G (reprint author), Gustave Roussy Canc Campus, Metabol & Cell Biol Platforms, Villejuif, France.; Castedo, M; Kroemer, G (reprint author), Ctr Rech Cordeliers, Equipe Labellisee Ligue Natl Canc 11, Paris, France.; Castedo, M; Kroemer

EMBO JOURNAL, 2018; 37 (14):

Abstract

Cisplatin is the most widely used chemotherapeutic agent, and resistance of neoplastic cells against this cytoxicant poses a major problem in clinical......

Full Text Link